TRANSITION AND SEPARATION AGREEMENTTransition and Separation Agreement • May 8th, 2017 • Achaogen Inc • Pharmaceutical preparations • California
This Transition and Separation Agreement (the “Agreement”) by and between Dr. Ian Friedland (“Executive”) and Achaogen, Inc., a Delaware corporation (the “Company”), is made effective as March 15, 2017 (the “Effective Date”) with reference to the following facts:
COLLABORATIVE DEVELOPMENT AND COMMERCIALIZATION AGREEMENTCollaborative Development and Commercialization Agreement • May 8th, 2017 • Achaogen Inc • Pharmaceutical preparations • Delaware
This Collaborative Development and Commercialization Agreement (“Agreement”) is entered into as of April 26, 2016 (“Effective Date”) by and between Microgenics Corporation (hereinafter “Microgenics”), having its principal place of business at 46500 Kato Road, Fremont, California 94538, and Achaogen Inc. (hereinafter “Achaogen”), having a place of business at 7000 Shoreline Court, #371, South San Francisco, California 94080. Both Microgenics and Achaogen are referred to herein individually as a “Party” and collectively as the “Parties.”
CONSULTING AGREEMENTConsulting Agreement • May 8th, 2017 • Achaogen Inc • Pharmaceutical preparations • California
This Consulting Agreement (the “Agreement”) is made and entered into as of March 15, 2013 (the “Effective Date”), by and between ACHAOGEN, INC., a Delaware corporation with its principal place of business at 7000 Shoreline Court, Suite 371, South San Francisco, California 94080, USA (“Achaogen”), and PLANET PHARMA, LLC an Illinois corporation having a principal place of business at 800 Hillgrove Avenue, Suite 102, Western Springs, IL 60558 (“Consultant”). Achaogen desires to retain Consultant as an independent contractor to perform consulting services for Achaogen and Consultant is willing to perform such services, on terms set forth more fully below.
VALIDATION AND MANUFACTURING AGREEMENTConfidential Treatment • May 8th, 2017 • Achaogen Inc • Pharmaceutical preparations • New York
THIS AGREEMENT is made and entered into this 5th day of March, 2017 (the “Effective Date”), by and between Achaogen, Inc., a company with its principal place of business at 7000 Shoreline Court, Suite 371, South San Francisco, CA, USA (“ACHAOGEN”) and Hovione Limited, a company with its principal place of business at Loughbeg, Ringaskiddy, Cork, County Cork, Ireland (“HOVIONE”). ACHAOGEN and HOVIONE may also hereinafter be referred to individually as a “Party” or collectively as the “Parties”.
